Duration of Dual Antiplatelet Therapy After Coronary Stenting

MLA

Konstantinos Mourouzis, et al. “Duration of Dual Antiplatelet Therapy After Coronary Stenting.” Current Pharmaceutical Design, vol. 22, Sept. 2016, pp. 4583–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....59f7b389c0491d16f95960d635dae8ed&authtype=sso&custid=ns315887.

APA

Konstantinos Mourouzis, Alexandros Briasoulis, Angeliki Papapanagiotou, Christodoulos Stefanadis, Georgia Vogiatzi, Evangelos Oikonomou, Athanasios G. Papavassiliou, Gerasimos Siasos, Nikolaos Papageorgiou, Theodore G. Papaioannou, Thodoris Zografos, Manolis Vavuranakis, & Dimitris Tousoulis. (2016). Duration of Dual Antiplatelet Therapy After Coronary Stenting. Current Pharmaceutical Design, 22, 4583–4595.

Chicago

Konstantinos Mourouzis, Alexandros Briasoulis, Angeliki Papapanagiotou, Christodoulos Stefanadis, Georgia Vogiatzi, Evangelos Oikonomou, Athanasios G. Papavassiliou, et al. 2016. “Duration of Dual Antiplatelet Therapy After Coronary Stenting.” Current Pharmaceutical Design 22 (September): 4583–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....59f7b389c0491d16f95960d635dae8ed&authtype=sso&custid=ns315887.